PROLANZA olanzapine 7.5mg tablet blister pack

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

şimdi satın al

Aktif bileşen:

olanzapine, Quantity: 7.5 mg

Mevcut itibaren:

Medis Pharma Pty Ltd

INN (International Adı):

Olanzapine

Farmasötik formu:

Tablet, film coated

Kompozisyon:

Excipient Ingredients: magnesium stearate; microcrystalline cellulose; hyprolose; purified talc; crospovidone; lactose monohydrate; titanium dioxide; xanthan gum; polyvinyl alcohol; lecithin

Uygulama yolu:

Oral

Paketteki üniteler:

7, 50, 14, 10, 21, 30, 20, 40, 60, 28

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

For the treatment of schizophrenia and related psychoses. ,Alone or in combination with lithium or valproate, it is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ,For preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.

Ürün özeti:

Visual Identification: White, round, biconvex film coated tablets; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

2011-08-11